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Aims
Clinical features of hyperinsulinism-hyperammonaemia
syndrome are variable. A potential genotype-phenotype
correlation of GLUD1 mutation and clinical features has
been suggested. We here report the long-term outcome
of a child with hyperinsulinism-hyperammonaemia
syndrome.
Methods
A male infant was born at 38 gestational weeks with
birth weight of 3.605 kg. He presented with convulsion
at 28 days of life. Physical examination was unremark-
able. He was initially treated as meningoencephalitis. CT
brain was unremarkable. Bacterial and viral cultures
were negative. Plasma glucose upon admission was
1.2 mmol/l with negative urine ketone. Glucose infusion
was high up to 12.1 mg/kg/min. Two sets of critical
samples were obtained during hypoglycaemia.
Workup for metabolic diseases was unremarkable.
But ammonia levels were persistently high up to 252-
353 umol/l. Octreotide injection was started to achieve
euglycaemia. Protein free diet was tried but without suc-
cess in lowering ammonia levels. Octreotide was later
switched to oral diazoxide and hydrochlorothiazide. Full
enteral feeding was established with stable glucose levels.
Results
Genetic analysis showed a mutation in axon 10;
Asn410I1e (N410I), a mutation of AAC to ATC at
codon 410. The diagnosis of hyperinsulinism-hyperam-
monaemia syndrome was confirmed. We follow the
child until he is 6 years of age. Home blood glucose
monitoring prevented him from hypoglycaemia. Fasting
test was performed every year to fine tune his diazoxide
dosage. He remained seizure free while ammonia levels
remained high up to 123-218 µmol/l. Formal develop-
mental assessment performed at 5 years of age showed
delay in cognitive and speech development for 1-
1.5 years, and attention-deficit hyperactivity syndrome.
Conclusion
Clinical features of hyperinsulinism-hyperammonaemia
syndrome are variable. A genotype-phenotype correla-
tion requires confirmation in larger series of patients.
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Table 1
Date 28 days of life 34 days of life
Plasma glucose (mmol/l) 1.9 2.0
Insulin (mIU/l) 23.9 10.5
Growth hormone (IU/l) 54
Cortisol (nmol/l) 311
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